• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在胰十二指肠切除术治疗腺癌时,计划性与非计划性门静脉切除术。

Planned versus unplanned portal vein resections during pancreaticoduodenectomy for adenocarcinoma.

机构信息

Hepatopancreatobiliary Surgical Oncology, Princess Margaret Cancer Center, University Health Network, University of Toronto, Toronto, Ontario, Canada.

出版信息

Br J Surg. 2013 Sep;100(10):1349-56. doi: 10.1002/bjs.9222.

DOI:10.1002/bjs.9222
PMID:23939847
Abstract

BACKGROUND

The management of portal vein (PV) involvement by pancreatic adenocarcinoma during pancreaticoduodenectomy (PD) is controversial. The aim of this study was to compare the outcomes of unplanned and planned PV resections as part of PD.

METHODS

An analysis of PD over 11 years was performed. Patients who had undergone PV resection (PV-PD) were identified, and categorized into those who had undergone planned or unplanned resection. Postoperative and oncological outcomes were compared.

RESULTS

Of 249 patients who underwent PD for pancreatic adenocarcinoma, 66 (26·5 per cent) had PV-PD, including 27 (41 per cent) planned and 39 (59 per cent) unplanned PV resections. Twenty-five of 27 planned PV resections were circumferential PV-PD, whereas 25 of 39 unplanned PV resections were partial PV-PD. Planned PV resections were performed in slightly younger patients (mean(s.d.) 60(9) versus 65(10) years; P = 0·031), and associated with longer operating times (mean(s.d.) 602(131) versus 458(83) min; P < 0·001) and more major complications (26 versus 5 per cent; P = 0·026). Planned PV resections were associated with a lower rate of positive margins (4 versus 44 per cent; P < 0·001) despite being carried out for larger tumours (mean(s.d.) 3·9(1·4) versus 2·9(1·0) cm; P = 0·002). There was no difference in survival between the two groups (P = 0·998). On multivariable analysis, margin status was a significant predictor of survival.

CONCLUSION

Although planned PV resections for pancreatic adenocarcinoma were associated with higher rates of postoperative morbidity than unplanned resections, R0 resection rates were better.

摘要

背景

在胰十二指肠切除术(PD)中,对于胰腺癌累及门静脉(PV)的处理存在争议。本研究旨在比较 PD 中计划性和非计划性 PV 切除的结果。

方法

对 11 年来的 PD 进行了分析。确定了接受 PV 切除(PV-PD)的患者,并将其分为计划性和非计划性切除。比较了术后和肿瘤学结果。

结果

在 249 例接受 PD 治疗的胰腺腺癌患者中,66 例(26.5%)行 PV-PD,其中 27 例(41%)为计划性,39 例(59%)为非计划性。27 例计划性 PV 切除中,25 例行环形 PV-PD,39 例非计划性 PV 切除中,25 例行部分 PV-PD。计划性 PV 切除术的患者年龄稍轻(平均(标准差)60(9)岁比 65(10)岁;P=0.031),手术时间较长(平均(标准差)602(131)分钟比 458(83)分钟;P<0.001),且主要并发症发生率较高(26%比 5%;P=0.026)。尽管计划切除的肿瘤较大(平均(标准差)3.9(1.4)cm 比 2.9(1.0)cm;P=0.002),但计划性 PV 切除的阳性切缘率较低(4%比 44%;P<0.001)。两组患者的生存情况无差异(P=0.998)。多变量分析显示,切缘状态是生存的显著预测因素。

结论

虽然计划行 PV 切除术治疗胰腺癌与非计划性切除术相比,术后并发症发生率较高,但 R0 切除率更高。

相似文献

1
Planned versus unplanned portal vein resections during pancreaticoduodenectomy for adenocarcinoma.在胰十二指肠切除术治疗腺癌时,计划性与非计划性门静脉切除术。
Br J Surg. 2013 Sep;100(10):1349-56. doi: 10.1002/bjs.9222.
2
Outcomes of vascular resection in pancreaticoduodenectomy: single-surgeon experience.胰十二指肠切除术中血管切除的结果:单术者经验
Am Surg. 2013 Oct;79(10):1064-7.
3
Prosthetic graft reconstruction after portal vein resection in pancreaticoduodenectomy: a multicenter analysis.胰十二指肠切除术后门静脉切除后假体移植重建:多中心分析。
J Am Coll Surg. 2010 Sep;211(3):316-24. doi: 10.1016/j.jamcollsurg.2010.04.005. Epub 2010 Jun 8.
4
Clinical significance of portal-superior mesenteric vein resection in pancreatoduodenectomy for pancreatic head cancer.胰头癌胰十二指肠切除术中门静脉-肠系膜上静脉切除的临床意义。
Pancreas. 2012 Jan;41(1):102-6. doi: 10.1097/MPA.0b013e318221c595.
5
Grafts for mesenterico-portal vein resections can be avoided during pancreatoduodenectomy.在胰十二指肠切除术期间,可以避免进行肠系膜门静脉切除吻合术。
J Am Coll Surg. 2012 Oct;215(4):569-79. doi: 10.1016/j.jamcollsurg.2012.05.034. Epub 2012 Jul 3.
6
Segmental resection and wedge excision of the portal or superior mesenteric vein during pancreatoduodenectomy.胰十二指肠切除术中门静脉或肠系膜上静脉的节段性切除和楔形切除。
Surgery. 2001 Feb;129(2):158-63. doi: 10.1067/msy.2001.110221.
7
Should the portal vein be routinely resected during pancreaticoduodenectomy for adenocarcinoma?在胰十二指肠切除术治疗腺癌时是否应常规切除门静脉?
Ann Surg. 2013 Apr;257(4):726-30. doi: 10.1097/SLA.0b013e318269d23c.
8
Portal or superior mesenteric vein resection for pancreatic head adenocarcinoma: prognostic value of the length of venous resection.胰头腺癌门静脉或肠系膜上静脉切除:静脉切除长度的预后价值
Surgery. 2009 Apr;145(4):417-25. doi: 10.1016/j.surg.2008.12.009. Epub 2009 Feb 23.
9
Pancreaticoduodenectomy with vascular resection: margin status and survival duration.血管切除的胰十二指肠切除术:切缘状态与生存时长
J Gastrointest Surg. 2004 Dec;8(8):935-49; discussion 949-50. doi: 10.1016/j.gassur.2004.09.046.
10
Portal or superior mesenteric vein resection in pancreatoduodenectomy for pancreatic head carcinoma.胰头癌胰十二指肠切除术中门静脉或肠系膜上静脉切除。
Br J Surg. 2015 Jun;102(7):837-46. doi: 10.1002/bjs.9799. Epub 2015 Apr 15.

引用本文的文献

1
Robotic Versus Open Pancreatoduodenectomy With Vein Resection and Reconstruction: A Propensity Score-Matched Analysis.机器人辅助与开放胰十二指肠切除术加静脉切除与重建:一项倾向评分匹配分析。
Ann Surg Open. 2024 Mar 26;5(2):e409. doi: 10.1097/AS9.0000000000000409. eCollection 2024 Jun.
2
REDISCOVER International Guidelines on the Perioperative Care of Surgical Patients With Borderline-resectable and Locally Advanced Pancreatic Cancer.重新发现关于伴可切除和局部进展期胰腺癌手术患者围手术期护理的国际指南。
Ann Surg. 2024 Jul 1;280(1):56-65. doi: 10.1097/SLA.0000000000006248. Epub 2024 Feb 26.
3
Preoperative Decision to Perform Portal Vein Resection Improves Survival in Patients With Resectable Pancreatic Head Cancer Adjacent to Portal Vein.
术前决定行门静脉切除可提高门静脉旁可切除胰头癌患者的生存率。
Ann Surg Open. 2021 May 5;2(2):e064. doi: 10.1097/AS9.0000000000000064. eCollection 2021 Jun.
4
Practical implications of tumor proximity to landmark vessels in minimally invasive radical antegrade modular pancreatosplenectomy.微创根治性顺行模块化胰脾切除术时肿瘤与标志性血管毗邻的实际意义。
Updates Surg. 2023 Sep;75(6):1533-1540. doi: 10.1007/s13304-023-01584-7. Epub 2023 Jul 17.
5
Ligamentum teres hepatis as a graft for portal and/or superior mesenteric vein reconstruction: From bench to bedside.肝圆韧带作为门静脉和/或肠系膜上静脉重建的移植物:从实验台到临床应用
World J Gastrointest Surg. 2023 Apr 27;15(4):674-686. doi: 10.4240/wjgs.v15.i4.674.
6
Surgical Treatment of Pancreatic Cancer: Currently Debated Topics on Vascular Resection.胰腺癌的外科治疗:血管切除的当前争议性话题。
Cancer Control. 2023 Jan-Dec;30:10732748231153094. doi: 10.1177/10732748231153094.
7
Tips and tricks for robotic pancreatoduodenectomy with superior mesenteric/portal vein resection and reconstruction.机器人胰十二指肠切除术伴肠系膜上/门静脉切除与重建的技巧。
Surg Endosc. 2023 Apr;37(4):3233-3245. doi: 10.1007/s00464-022-09860-0. Epub 2023 Jan 9.
8
Vascular Resection in Pancreatectomy-Is It Safe and Useful for Patients with Advanced Pancreatic Cancer?胰腺癌手术中的血管切除——对晚期胰腺癌患者是否安全且有效?
Cancers (Basel). 2022 Feb 25;14(5):1193. doi: 10.3390/cancers14051193.
9
Venous wedge and segment resection during pancreatoduodenectomy for pancreatic cancer: impact on short- and long-term outcomes in a nationwide cohort analysis.在胰十二指肠切除术治疗胰腺癌期间进行静脉楔型和节段切除术:全国队列分析对短期和长期结果的影响。
Br J Surg. 2021 Dec 17;109(1):96-104. doi: 10.1093/bjs/znab345.
10
Surgery for locally advanced pancreatic ductal adenocarcinoma-is it only about the vessels?局部晚期胰腺导管腺癌的手术治疗——仅仅关乎血管吗?
J Gastrointest Oncol. 2021 Oct;12(5):2503-2511. doi: 10.21037/jgo-20-313.